Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice

Peter Bramlage1 Institut für Pharmakologie und präventive Medizin, Mahlow, GermanyCorrespondence[email protected]

Eva-Maria Fronk2 Daiichi Sankyo Europe GmbH, Munich, Germany

Wolf-Peter Wolf3 Daiichi Sankyo Deutschland GmbH, Munich, Germany

Rüdiger Smolnik3 Daiichi Sankyo Deutschland GmbH, Munich, Germany

Gemma Sutton1 Institut für Pharmakologie und präventive Medizin, Mahlow, Germany

Roland E Schmieder4 Abteilung für Nephrologie und Hypertensiologie, Universitätsklinikum Erlangen, Erlangen, Germany

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (6)

Michel Burnier, Josep Redon & Massimo Volpe. (2023) Single-Pill Combination with Three Antihypertensive Agents to Improve Blood Pressure Control in Hypertension: Focus on Olmesartan-Based Combinations. High Blood Pressure & Cardiovascular Prevention 30:2, pages 109-121.
Crossref

Il Suk Sohn, Sang-Hyun Ihm, Gee Hee Kim, Sang Min Park, Bum-Kee Hong, Chang Hoon Lee, Sang Hyun Lee, Dae-Il Chang, Sung-Pil Joo, Sang-Chan Lee, Yong-ho Lee, Dong Woon Jeon, Kyung Tae Jung, Si Jae Rhee, Yoon-Jin Cho, Chong-Jin Kim, Yun Sung Kim, Seong-Ill Woo, Kyounghoon Lee, Jung Ho Heo, Sang-Ho Park, Euy Jin Choi, Sun Ho Hwang, Yonh-Gu Chung, Young Jin Youn, Eul-Soon Im, Jong Sam Baik, Nack-Cheon Choi, Jin Bae Lee, Kyu-Hyung Ryu, Ji-Yong Jang, Sung-Ji Park, Dong-Ick Shin, Jin Oh. Na, Yun Jae Chung, Su Hyun Kim, Jong-Young Lee, Yoon-Sang Oh, Jong Hwan Choi, Hye Sun Seo, Su Kyoung Kwon, Hyung-Jun Kim, Jin-Sun Park, Kyoung-Ha Park, Kyoung-Soo Lee, Sung Chang Chung, Han-Jin Cho, Chang-Min Lee, Sung-Rae Kim, Jinkwon Kim, Hyeong-gyun Oh, Ik Seong Park, Pil-Wook Chung, Sung-Rae Cho, Hyun-Seung Kang, Seung Jin Lee, Kyungil Park, Si Won Lee, Jang-Won Son, Soo Kyoung Kim, Joong-Hwa Chung, Jin-Soo Byon, Hong Euy Lim, Bum-Tae Kim, Yu Jeong Choi, Soe Hee Ann, Sang Min Sung & Jun-Hee Lee. (2021) Real-world evidence on the strategy of olmesartan-based triple single-pill combination in Korean hypertensive patients: a prospective, multicenter, observational study (RESOLVE-PRO). Clinical Hypertension 27:1.
Crossref

Jaejin An, Catherine G. Derington, Tiffany Luong, Kari L. Olson, Jordan B. King, Adam P. Bress & Cynthia A. Jackevicius. (2020) Fixed-Dose Combination Medications for Treating Hypertension: A Review of Effectiveness, Safety, and Challenges. Current Hypertension Reports 22:11.
Crossref

Sung-Ji Park & Si Jae Rhee. (2020) Real-World Effectiveness and Safety of a Single-Pill Combination of Olmesartan/Amlodipine/Hydrochlorothiazide in Korean Patients with Essential Hypertension (RESOLVE): A Large, Observational, Retrospective, Cohort Study. Advances in Therapy 37:8, pages 3500-3514.
Crossref

Katherine A. Lyseng-Williamson. (2017) Olmesartan medoxomil/amlodipine/hydrochlorothiazide 20 mg/5 mg/12.5 mg fixed-dose combination in hypertension: a profile of its use. Drugs & Therapy Perspectives 34:1, pages 1-7.
Crossref

Roland E. Schmieder, Agnes Jumar, Eva-Maria Fronk, Ana-Filipa Alexandre & Peter Bramlage. (2017) Quality of life and emotional impact of a fixed-dose combination of antihypertensive drugs in patients with uncontrolled hypertension. The Journal of Clinical Hypertension 19:2, pages 126-134.
Crossref

Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice

Articles from other publishers (6)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice

Citations (6)

Articles from other publishers (6)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date